|
General overview
All students must complete six co-curricular activities to be eligible for graduation. These activities must be completed as part of SPPD I and SPPD II courses (3 activities per course offering for a total of six).
Participation in at least four of the activities must be live (on-site or via synchronous virtual offering). Students may participate/complete up to two non-live activities by utilizing resources such as recordings, readings, and podcasts.
Students can participate in co-curricular activities offered through SOP-W/M or outside SOP-W/M. For activities not offered through the school, approval must be granted to receive credit for participation.
This documentation is for a co-curricular activity linked primarily to Innovation and Entrepreneurship.
|
| Questions |
|
SPPD I | SPPD II |
|
|
| |
This activity is meeting a requirement for (please select one) | Required | SPPD I | | | | | |
|
| Questions |
|
Yes | No |
|
|
| |
Was the activity delivered through SOP-W/M? | Required | Yes | | | | | |
|
***If No- was approval granted for participation (approval must be obtained from Dr. Carrie Graham or Professor Anthony Pollano)
If Approval was granted, please enter the Date of Approval below. |
|
N/A; This activity is delivered through SOP
|
|
Comments:
|
| The Med List: Understanding The "Math" of Prescribing & Deprescribing |
|
|
|
|
|
Name of Presenter(s)/Activity Leader(s) |
|
Comments:
|
| Dr. Donna Barlett & Kevin |
|
|
What is the method of delivery for this activity? If Other, please comment below.
**For activities that are not live or not offered through SOP-W/M, please insert a link to the activity if available (e.g. video, citation of book, etc). |
|
Podcast/Ted Talk
|
In 10 to 15 sentences, please describe how this co-curricular activity made you aware of the importance of creative thinking and decision-making to overcome barriers that commonly confront pharmacists in delivering quality care. Think of a barrier you might confront and what will be your creative idea or approach to overcome the barrier? |
|
Comments:
|
Monitoring is crucial not only to prescribe and to do the deprescribing as well. How to incorporate the entire medical team in the math of adding medicine or deprescribing. Deprescribing medication can help improve patient adherence to treatment plans, as patients are more likely to adhere to a regimen that includes fewer medications. Reducing healthcare costs, and improving patient adherence and increase overall outcome to treatment plans. It is essential for healthcare providers to carefully evaluate patients' medication regimens and consider deprescribing when appropriate to optimize patient outcomes.
Another term that was mentioned in the podcast was Polypharmacy, which refers to the use of multiple medications by a single patient, can contribute to the development of anticholinergic burden. Anticholinergic burden refers to the cumulative effect of medications that block the action of acetylcholine, a neurotransmitter that plays a crucial role in various bodily functions, including memory, attention, and muscle contraction.
Polypharmacy can lead to anticholinergic burden in several ways:
1. Increased risk of adverse effects: When patients are prescribed multiple medications, the risk of adverse effects increases. Anticholinergic medications, in particular, can have a range of adverse effects, including dry mouth, constipation, urinary retention, and cognitive impairment.
2. Drug-drug interactions: Polypharmacy increases the risk of drug-drug interactions, which can enhance the anticholinergic effects of medications. For example, combining an anticholinergic medication with another medication that has anticholinergic properties can increase the risk of anticholinergic adverse effects.
3. Increased medication exposure: Polypharmacy can lead to increased exposure to medications, which can increase the risk of anticholinergic burden. The more medications a patient is taking, the greater the risk of cumulative anticholinergic effects.
4. Increased risk of medication errors: Polypharmacy can increase the risk of medication errors, such as dosing errors or drug interactions. This can lead to increased anticholinergic exposure and burden.
5. Increased risk of geriatric syndromes: Polypharmacy is a common problem in older adults, who are more susceptible to the adverse effects of medications, including anticholinergic effects. Geriatric syndromes, such as delirium, falls, and cognitive impairment, can be caused or exacerbated by anticholinergic burden.
6. Increased risk of hospitalization: Polypharmacy can increase the risk of hospitalization due to frialty and falls, particularly in older adult. |
|
|